Results 11 to 20 of about 111,529 (192)

HELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia.

PLoS ONE, 2014
BackgroundPentraxin 3 (PTX3), a key component of the humoral arm of innate immunity, is secreted by vascular cells in response to injury, possibly aiming at tuning arterial activation associated with vascular damage.
Michela Zanetti, Mariagrazia Zenti, Rocco Barazzoni, Federica Zardi, Annamaria Semolic, Michele Giuseppe Messa, Filippo Mearelli, Gianpaolo Russi, Maurizio Fonda, Luca Scarano, Enzo Bonora, Luigi Cattin   +11 more
doaj   +2 more sources

LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection

Journal of Lipid Research, 2011
Subnormal HDL-cholesterol (HDL-C) and apolipoprotein (apo)AI levels are characteristic of familial hypercholesterolemia (FH), reflecting perturbed intravascular metabolism with compositional anomalies in HDL particles, including apoE enrichment. Does LDL-
Alexina Orsoni, Samir Saheb, Johannes H.M. Levels, Geesje Dallinga-Thie, Marielle Atassi, Randa Bittar, Paul Robillard, Eric Bruckert, Anatol Kontush, Alain Carrié, M. John Chapman   +10 more
doaj   +2 more sources

Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia

Journal of Lipid Research, 2012
In familial hypercholesterolemia (FH), low HDL cholesterol (HDL-C) levels are associated with functional alterations of HDL particles that reduce their capacity to mediate the reverse cholesterol transport (RCT) pathway.
Alexina Orsoni, Elise F. Villard, Eric Bruckert, Paul Robillard, Alain Carrie, Dominique Bonnefont-Rousselot, M. John Chapman, Geesje M. Dallinga-Thie, Wilfried Le Goff, Maryse Guerin   +9 more
doaj   +2 more sources

Platelet aggregation and lipoprotein levels in a patient with familial hypercholescholesterolemia after selective LDL-apheresis

São Paulo Medical Journal
Platelet aggregation was studied in a patient with familial hypercholesterolemia immediately after aphereis selective for low-density lipoprotein (LDL), a lipid-lowering procedure.This treatment reduced plasmatic levels of total and LDL-cholesterol, apo ...
Madalena Nunes da Silva Pares, Elbio Antonio D'Amico, José Mauro Kutner, Dalton de Alencar Fischer Chamone, Sergio Paulo Bydlowski   +4 more
doaj   +2 more sources

Intraprocedural Hemodynamics During Concomitant Rheocarna Therapy and Maintenance Hemodialysis: Effects of Dialyzer Membrane Type and Circuit Sequence. [PDF]

J Clin Apher
ABSTRACT Chronic limb‐threatening ischemia (CLTI), a severe manifestation of peripheral artery disease, is particularly prevalent among patients receiving maintenance hemodialysis (HD) and is associated with poor limb and survival outcomes. Low‐density lipoprotein (LDL) apheresis, including Rheocarna, is used as adjunctive therapy for refractory CLTI ...
Ishizuka Y, Sato G, Ishigaki S, Enoki R, Kajiwara K, Nakasato A, Kinomura S, Kin S, Noguchi Y, Yoshizawa D, Kikuchi K, Abe M, Kumagai K, Tanaka T, Okamoto K.   +14 more
europepmc   +2 more sources

Effectiveness of a Novel Low-Density Lipoprotein Apheresis Device Rheocarna in Patients Undergoing Hemodialysis With Chronic Limb-Threatening Ischemia: A Single-Center Retrospective Study. [PDF]

Ther Apher Dial
ABSTRACT Background Chronic limb‐threatening ischemia (CLTI) is a severe form of lower‐extremity artery disease characterized by distal lesions and microcirculatory impairment, limiting revascularization efficacy. Rheocarna is a direct hemoperfusion low‐density lipoprotein (LDL) adsorption device with potential rheological and anti‐inflammatory ...
Ishioka K, Ohtake T, Ohmori K, Shibuya C, Tsukahara T, Yamano M, Mochida Y, Oka M, Maesato K, Tsukamoto Y, Moriya H, Hidaka S, Kobayashi S.   +12 more
europepmc   +2 more sources

The scientific basis and future of lipoprotein apheresis [PDF]

, 2021
Lipoprotein apheresis plays a vital role in the management of the severe hyperlipidemias that predispose to atherosclerosis. Determinants of efficacy are the acute reduction in lipoproteins achieved by each apheresis procedure, their frequency, and the ...
Gilbert R. Thompson, Thompson, Gilbert R
core   +1 more source

Biocompatibility in low-density lipoprotein apheresis and plasma separation [PDF]

, 2021
Introduction: Low-density lipoprotein (LDL) apheresis is used for the removal of LDL in selected patients and is also used for other medical indications.
Hardersen, Randolf Inge
core   +1 more source

The world apheresis association registry, 2023 update

, 2023
The WAA apheresis registry contains data on more than 140,000 apheresis procedures conducted in 12 different countries. The aim is to give an update of indications, type and number of procedures and adverse events (AEs).
Kielstein, Jan, Astrid Aandahl, Seval, Guldane Cengiz,, Le Poole, Kaatje,, Michael Ott, Fredrik Toss, Griskevicius, Antanas,, Bojanic, Ines,, Aandahl, Astrid,, Griskevicius, Antanas, Derfler, Kurt, Dries Deeren, Derfler, Kurt,, Gösta Berlin, Vrielink, Hans,, Prophet, Heinrich,, Judita Audzijoniene, Milan Blaha, Audzijoniene, Judita,, Heinrich Prophet, Guldane Cengiz Seval, Audzijoniene, Judita, Elizabeth Newman, Volker Witt, Blahutova, Sarka, Strineholm, Virginia, Hans Vrielink, Stegmayr, Bernd,, Ines Bojanic, Newman, Elizabeth,, Hrdlickova, Radomira,, Zdenka Bhuiyan-Ludvikova, Witt, Volker, Gasova, Zdenka,, Blaha, Milan,, Thomas Nilsson, Blaha, Milan, Berlin, Gösta, Berlin, Gösta,, Bhuiyan-Ludvikova, Zdenka, Hrdlickova, Radomira, Lanska, Miriam,, Toss, Fredrik, Ilhan, Osman,, Blahutova, Sarka,, Glatt, Tanya, Tanya Glatt, Strineholm, Virginia,, Kaatje Le Poole, Le Poole, Kaatje, Lanska, Miriam, Bojanic, Ines, Newman, Elizabeth, Ilhan, Osman, Radomira Hrdlickova, Antanas Griskevicius, Ott, Michael, Gasova, Zdenka, Seval, Guldane Cengiz, Miriam Lanska, Zdenka Gasova, Virginia Strineholm, Bernd Stegmayr, Glatt, Tanya,, Kielstein, Jan,, Toss, Fredrik,, Deeren, Dries,, Prophet, Heinrich, Nilsson, Thomas, Deeren, Dries, Jan Kielstein, Osman Ilhan, Aandahl, Astrid, Vrielink, Hans, Ott, Michael,, Kurt Derfler, Nilsson, Thomas,, Witt, Volker,, Sarka Blahutova, Stegmayr, Bernd, Bhuiyan-Ludvikova, Zdenka,   +80 more
core   +1 more source

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundApheresis is an important treatment for reducing low‐density lipoprotein cholesterol (LDL‐C) in patients with familial hypercholesterolemia (FH). We systematically reviewed the current literature surrounding LDL‐C apheresis for FH.
Anthony Wang, Akshara Richhariya, Shravanthi R. Gandra, Brian Calimlim, Lisa Kim, Ruben G. W. Quek, Robert J. Nordyke, Peter P. Toth   +7 more
doaj   +1 more source